Revolution Medicines
Company ● Covered in 1 story + Follow ✴ AI Graph
This profile is built automatically from TLDRocket coverage.
Signals
0 stories (-100%)
Media momentum
As of 20 Oct 2026 · Visible stories in the last 30 days, compared with the 30 days before.
1 source
Source diversity
As of 20 Oct 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 20 Oct 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 20 Oct 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Aug 2026
Coverage span
As of 20 Oct 2026 · First to most recent month of TLDRocket coverage of this entity.
Management
updated 4 Oct 2026- Mark A. Goldsmith President, CEO & Board Chairman
- Peg Horn Chief Operating Officer
- Wei Lin Chief Medical Officer
- Luan M. Wilfong Chief Human Resources Officer
- Steve Kelsey Senior Advisor
- Ryan Asay SVP, Corporate Affairs
- Colby Leno Senior Vice President, Head of Lifecycle and Portfolio Leadership
- Gerwin Winter Senior Vice President Head of Europe at Revolution Medicines
- Laurent Bride EVP, Chief Digital & Information Officer
- Na Xu Executive Director
- Eric Chown Svp, Global Commercial Development
- Anthony Mancini Chief Global Commercialization Officer
+ 28 more tracked
Latest developments
2026
Relationships
Products & technology
- Develops Rasonque · 1 source
People
- Employed by Dr. Danish Nagda · 1 source